SEC Form 4 · accession 0001493152-19-001144
Ernexa Therapeutics Inc. · ERNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Allen Wolff
Officer — CFO and EVP
Period of report
Jan 29, 2019
Accepted (ET)
Jan 29, 2019 · 8:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 29, 2019 | F | 171 | $3.18 | D | 49,254 | D | |
| Common StockF2 | holding | — | — | — | 2,100 | I | See footnote | |
| Common StockF3 | holding | — | — | — | 2,100 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on January 29, 2019. No shares were sold in connection with this transaction.
- F2As custodian of Minor Child 1.
- F3As custodian of Minor Child 2.